Literature DB >> 33219937

Meta-analysis of laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma.

Nikolaos Machairas1,2, Ioannis D Kostakis3, Dimitrios Schizas4, Stylianos Kykalos5, Nikolaos Nikiteas5, Georgios C Sotiropoulos5.   

Abstract

Intrahepatic cholangiocarcinoma (iCCA) is a rare and aggressive hepatic malignancy. An up-to-date systematic review and meta-analysis was conducted aiming to compare outcomes between laparoscopic (LLR) and open liver resection (OLR) for patients with iCCA. A systematic literature search of Medline, Scopus, Google Scholar, and Cochrane databases was performed. A total of 8 studies comprising 2872 patients, who underwent LLR or OLR for iCCA, were included in our meta-analysis. LLR patients had smaller tumors [mean difference (MD): - 1.17 cm, 95% confidence intervals (CI) - 1.77 to - 0.57, p = 0.0001], underwent major resections less frequently [risk ratio (RR): 0.75, 95% CI 0.67-0.83, p < 0.00001] and R0 resections more frequently (RR: 1.05, 95% CI 1.01-1.09, p = 0.01), while lymphadenectomy was less common in the laparoscopic group (RR: 0.73, 95% CI 0.58-0.92, p = 0.007). The LLR group presented reduced blood loss (MD: - 270.16 ml, 95% CI - 381.53 to - 32.79, p = 0.002), need for transfusion (RR: 0.39, 95% CI 0.21-0.73, p = 0.003), overall morbidity (RR: 0.58, 95% CI 0.4-0.83, p = 0.003) and hospital stay (MD: - 3.48 days, 95% CI: - 6.94 to - 0.02, p = 0.05) compared to the OLR group. No differences were shown in operative time (MD: 1.6 min, 95% CI - 34.17-37.37, p = 0.93), major morbidity (RR: 0.65, 95% CI 0.38-1.11, p = 0.12), mortality (RR: 1.42, 95% CI 0.13-15.07, p = 0.77), overall (HR: 0.9, 95% CI 0.59-1.38, p = 0.63) and relapse-free survival (HR: 0.77, 95% CI 0.5-1.16, p = 0.21) between the two groups. LLR seems to benefit patients with iCCA in terms of short-term outcomes, whilst long-term outcomes are comparable among the two approaches.

Entities:  

Keywords:  Intrahepatic cholangiocarcinoma; Laparoscopic liver resection; Minimally invasive; Recurrence; Survival

Mesh:

Year:  2020        PMID: 33219937     DOI: 10.1007/s13304-020-00930-3

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  39 in total

1.  Laparoscopic liver surgery: yesterday, today and tomorrow.

Authors:  Nikolaos Machairas; Georgios C Sotiropoulos
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

Review 2.  Cholangiocarcinoma: Epidemiology and risk factors.

Authors:  Shahid A Khan; Simona Tavolari; Giovanni Brandi
Journal:  Liver Int       Date:  2019-03-24       Impact factor: 5.828

3.  Comparison between robotic and open liver resection: a systematic review and meta-analysis of short-term outcomes.

Authors:  Nikolaos Machairas; Dimetrios Papaconstantinou; Diamantis I Tsilimigras; Dimitrios Moris; Anastasia Prodromidou; Anna Paspala; Eleftherios Spartalis; Ioannis D Kostakis
Journal:  Updates Surg       Date:  2019-02-04

Review 4.  Intrahepatic cholangiocarcinoma: current management and emerging therapies.

Authors:  Amir A Rahnemai-Azar; Allison B Weisbrod; Mary Dillhoff; Carl Schmidt; Timothy M Pawlik
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-03-29       Impact factor: 3.869

5.  Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.

Authors:  Mechteld C de Jong; Hari Nathan; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Cristina R Ferrone; Andrew X Zhu; Todd W Bauer; Dustin M Walters; T Clark Gamblin; Kevin T Nguyen; Ryan Turley; Irinel Popescu; Catherine Hubert; Stephanie Meyer; Richard D Schulick; Michael A Choti; Jean-Francois Gigot; Gilles Mentha; Timothy M Pawlik
Journal:  J Clin Oncol       Date:  2011-07-05       Impact factor: 44.544

6.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

Authors:  John Bridgewater; Peter R Galle; Shahid A Khan; Josep M Llovet; Joong-Won Park; Tushar Patel; Timothy M Pawlik; Gregory J Gores
Journal:  J Hepatol       Date:  2014-03-27       Impact factor: 25.083

Review 7.  Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives.

Authors:  Nikolaos Machairas; Hauke Lang; Kumar Jayant; Dimitri A Raptis; Georgios C Sotiropoulos
Journal:  Eur J Surg Oncol       Date:  2020-01-23       Impact factor: 4.424

8.  Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study.

Authors:  Thijs de Rooij; Jony van Hilst; Olivier R Busch; Marcel G Dijkgraaf; David A Kooby; Mohammed Abu Hilal; Marc G Besselink
Journal:  Ann Surg       Date:  2017-12       Impact factor: 12.969

9.  Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival.

Authors:  Lu Wu; Diamantis I Tsilimigras; Anghela Z Paredes; Rittal Mehta; J Madison Hyer; Katiuscha Merath; Kota Sahara; Fabio Bagante; Eliza W Beal; Feng Shen; Timothy M Pawlik
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

10.  Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.

Authors:  Supriya K Saha; Andrew X Zhu; Charles S Fuchs; Gabriel A Brooks
Journal:  Oncologist       Date:  2016-03-21
View more
  7 in total

Review 1.  Short-Term Outcomes After Robotic Versus Open Liver Resection: A Systematic Review and Meta-analysis.

Authors:  Konstantina Papadopoulou; Panagiotis Dorovinis; Stylianos Kykalos; Dimitrios Schizas; Paraskevas Stamopoulos; Gerasimos Tsourouflis; Dimitrios Dimitroulis; Nikolaos Nikiteas
Journal:  J Gastrointest Cancer       Date:  2022-02-24

2.  Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.

Authors:  Omid Salehi; Vera Kazakova; Eduardo A Vega; Onur C Kutlu; Sylvia V Alarcon; Richard Freeman; Olga Kozyreva; Claudius Conrad
Journal:  Surg Endosc       Date:  2021-11-08       Impact factor: 3.453

3.  Evaluation of nodal status in intrahepatic cholangiocarcinoma: a population-based study.

Authors:  Xiaoyuan Chen; Dawei Rong; Long Zhang; Chuangye Ni; Guoyong Han; Yiwei Lu; Xuejiao Chen; Yun Gao; Xuehao Wang
Journal:  Ann Transl Med       Date:  2021-09

Review 4.  Single-incision laparoscopic surgery to treat hepatopancreatobiliary cancer: A technical review.

Authors:  Shu-Hung Chuang; Shih-Chang Chuang
Journal:  World J Gastroenterol       Date:  2022-07-21       Impact factor: 5.374

Review 5.  Robotic-Assisted Surgery for Primary Hepatobiliary Tumors-Possibilities and Limitations.

Authors:  Julia Spiegelberg; Tanja Iken; Markus K Diener; Stefan Fichtner-Feigl
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639

Review 6.  Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach.

Authors:  Felix Krenzien; Nora Nevermann; Alina Krombholz; Christian Benzing; Philipp Haber; Uli Fehrenbach; Georg Lurje; Uwe Pelzer; Johann Pratschke; Moritz Schmelzle; Wenzel Schöning
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

Review 7.  Augmented Reality and Image-Guided Robotic Liver Surgery.

Authors:  Fabio Giannone; Emanuele Felli; Zineb Cherkaoui; Pietro Mascagni; Patrick Pessaux
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.